For the Inventor, By the Inventor

Enter assignee name

High Point, NC, United States of America

Transtech Pharma, Inc.

Calculating rank

USPTO Granted Patents = 49

% Expired Patents = 61.2

CIPO Patents = 2

EPO Patents = 11

Forward Citations = 769

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Adnan M M Mjalli (34 out of 74 patents)

Robert Carl Andrews (22 out of 53 patents)

Dharma Rao Polisetti (13 out of 53 patents)

4. Ramesh Gopalaswamy (11 out of 12 patents)

5. Christopher Behme (10 out of 12 patents)

6. Stephen Thomas Davis (10 out of 18 patents)

7. Mustafa Guzel (9 out of 34 patents)

8. Thomas Scott Yokum (9 out of 14 patents)

9. Kalpathy Chidambareswaran Santhosh (9 out of 19 patents)

10. Anitha Hari (8 out of 10 patents)

11. Muralidhar Bondlela (7 out of 10 patents)

12. Ghassan Qabaja (7 out of 7 patents)

13. Robert Rothlein (7 out of 7 patents)

14. Govindan Subramanian (7 out of 24 patents)

15. Jeff Jiqun Zhu (7 out of 20 patents)

Core Competencies:

Phenyl-Heteroaryl Derivatives

RAGE Fusion Proteins

Oxadiazoanthracene Compounds

GLP-1 Receptor Ligands

Benzazole Derivatives

Glucokinase Activators

Imidazole Derivatives

Carboxamide Derivatives

Therapeutic Agents

Aryl Compounds

Benzimidazole Derivatives

Nitrogen Heterocycles

49 patents: Sort by Forward Citations

1. 9045461 - Phenyl-heteroaryl derivatives and methods of use thereof (2015-06-02),

2. 9034341 - Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions (2015-05-19),

3. 8987295 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2015-03-24),

4. 8933222 - Oxadiazoanthracene compounds for the treatment of diabetes (2015-01-13),

5. 8877192 - Rage fusion proteins and methods of use (2014-11-04),

6. 8741900 - Phenyl-heteroaryl derivatives and methods of use thereof (2014-06-03),

7. 8718994 - Ligands for the GLP-1 receptor and methods for discovery thereof (2014-05-06),

8. 8703766 - Oxadiazoanthracene compounds for the treatment of diabetes (2014-04-22),

9. 8580833 - Substituted imidazole derivatives and methods of use thereof (2013-11-12),

10. 8524708 - Oxadiazoanthracene compounds for the treatment of diabetes (2013-09-03),

11. 8431575 - Phenyl-heteroaryl derivatives and methods of use thereof (2013-04-30),

12. 8404731 - Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors (2013-03-26),

13. 8383644 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2013-02-26),

14. 8377983 - Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors (2013-02-19),

15. 8372988 - Crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine (2013-02-12),

Company Overview

Transtech Pharma, Inc., based in High Point, NC, specializes in the development of innovative pharmaceutical compounds targeting various therapeutic areas. The company focuses on advanced chemical entities, including phenyl-heteroaryl derivatives and RAGE fusion proteins, as well as oxadiazoanthracene compounds and GLP-1 receptor ligands. Transtech's research encompasses a range of substituted imidazole and benzazole derivatives, alongside benzamide glucokinase activators and N-heteroaryl indole carboxamides, contributing to the advancement of modern medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

49 Patents

#4 in High Point, NC

#176 in North Carolina

#7,163 in US

#14,312 in the World

High Point, NC, United States of America

Transtech Pharma, Inc.

Forward Citations = 769

67 inventors:

Adnan M M Mjalli (34 out of 74 patents)

Robert Carl Andrews (22 out of 53 patents)

Dharma Rao Polisetti (13 out of 53 patents)

4. Ramesh Gopalaswamy (11 out of 12 patents)

5. Christopher Behme (10 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Transtech Pharma, Inc.. Retrieved from https://idiyas.com/company/transtech-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…